201 related articles for article (PubMed ID: 23786715)
1. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.
Wu HM; Wang HS; Huang HY; Lai CH; Lee CL; Soong YK; Leung PC
BMC Cancer; 2013 Jun; 13():300. PubMed ID: 23786715
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy.
Wu HM; Huang HY; Lee CL; Soong YK; Leung PC; Wang HS
Biol Reprod; 2015 Apr; 92(4):98. PubMed ID: 25761596
[TBL] [Abstract][Full Text] [Related]
3. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin-releasing hormone antagonist induces apoptosis in human decidual stromal cells: effect on GADD45α and MAPK signaling.
Wu HM; Wang HS; Soong YK; Huang HY; Chen CK; Lee CL; Leung PC
Hum Reprod; 2012 Mar; 27(3):795-804. PubMed ID: 22252084
[TBL] [Abstract][Full Text] [Related]
6. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.
Park DW; Choi KC; MacCalman CD; Leung PC
Reprod Biol Endocrinol; 2009 Aug; 7():81. PubMed ID: 19656390
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.
Wu HM; Huang HY; Schally AV; Chao A; Chou HH; Leung PC; Wang HS
Oncotarget; 2017 Jan; 8(3):4410-4421. PubMed ID: 28032599
[TBL] [Abstract][Full Text] [Related]
9. Roles of Src and epidermal growth factor receptor transactivation in transient and sustained ERK1/2 responses to gonadotropin-releasing hormone receptor activation.
Shah BH; Farshori MP; Jambusaria A; Catt KJ
J Biol Chem; 2003 May; 278(21):19118-26. PubMed ID: 12642580
[TBL] [Abstract][Full Text] [Related]
10. [Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN].
Zhao LJ; Wei LH; Li XP; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2009 Jan; 44(1):45-9. PubMed ID: 19563062
[TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone-II increases membrane type I metalloproteinase production via beta-catenin signaling in ovarian cancer cells.
Ling Poon S; Lau MT; Hammond GL; Leung PC
Endocrinology; 2011 Mar; 152(3):764-72. PubMed ID: 21239435
[TBL] [Abstract][Full Text] [Related]
12. Promotion of human trophoblasts invasion by gonadotropin-releasing hormone (GnRH) I and GnRH II via distinct signaling pathways.
Liu J; Maccalman CD; Wang YL; Leung PC
Mol Endocrinol; 2009 Jul; 23(7):1014-21. PubMed ID: 19372239
[TBL] [Abstract][Full Text] [Related]
13. Activation and nuclear translocation of PKCdelta, Pyk2 and ERK1/2 by gonadotropin releasing hormone in HEK293 cells.
Farshori PQ; Shah BH; Arora KK; Martinez-Fuentes A; Catt KJ
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):337-47. PubMed ID: 12943720
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
Kim KY; Choi KC; Auersperg N; Leung PC
Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289
[TBL] [Abstract][Full Text] [Related]
15. Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion.
Chen CL; Cheung LW; Lau MT; Choi JH; Auersperg N; Wang HS; Wong AS; Leung PC
Endocrine; 2007 Jun; 31(3):311-20. PubMed ID: 17906381
[TBL] [Abstract][Full Text] [Related]
16. IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells.
Lee EJ; Park SS; Kim WJ; Moon SK
Oncol Rep; 2012 Sep; 28(3):1084-90. PubMed ID: 22710862
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
Rangaswami H; Bulbule A; Kundu GC
J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A; Huerta-Reyes M; Maya-Núñez G; Arechavaleta-Velásco F; Conn PM; Ulloa-Aguirre A; Valdés J
BMC Cancer; 2012 Nov; 12():550. PubMed ID: 23176180
[TBL] [Abstract][Full Text] [Related]
19. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation.
Gründker C; Günthert AR; Millar RP; Emons G
J Clin Endocrinol Metab; 2002 Mar; 87(3):1427-30. PubMed ID: 11889221
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis.
Munshi HG; Wu YI; Mukhopadhyay S; Ottaviano AJ; Sassano A; Koblinski JE; Platanias LC; Stack MS
J Biol Chem; 2004 Sep; 279(37):39042-50. PubMed ID: 15247230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
